Japan

With the pandemic declared to be over in 2023, sales of both standard eye care and allergy eye care have benefited from increased opportunities to get out and about, a recovery in the number of inbound travellers, but also high pollen counts.…

Sales of digestive remedies continue to see a strong recovery in 2023 in current value terms. Sales are rebounding from the negative impact of the pandemic with the lifting of restrictions increasing the opportunities for consumers to go out to eat…

Similar to the pattern seen in vitamins, sales of dietary supplements continue to see steady growth in current value terms in 2023 due to increasing health consciousness. The market has been hit by the rising cost of raw materials and production…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…